Insulin Delivery Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Insulin Delivery Devices Market is segmented by Type (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, Jet Injectors), and Geography.

Insulin Delivery Devices Market Snapshot

Insulin Delivery Devices Market Overview
Study Period: 2016- 2026
Base Year: 2020
Fastest Growing Market: North America
Largest Market: Asia Pacific
CAGR: 3.5 %
Insulin Delivery Devices Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Insulin Delivery Devices market is expected to register a CAGR of 3.6% during the forecast period (2021 - 2026) with 35.5 billion revenue in 2020. The rapidly spreading epidemic of diabetes across the world has kept the interest level in diabetes-related R&D immensely high in recent years. Despite the condition affecting millions of people worldwide, scientists and researchers have not been able to find a cure for the disease. Controlling it by the adequate and timely administration of insulin remains an indispensable measure for patients with type-1 diabetes to lead a normal life. Thus, in the absence of a complete and effective cure for diabetes, the emphasis mainly lies in making insulin therapy better and more successful. As a result, the quest for new and pioneering treatments and insulin delivery measures continues and is reflecting positively on the overall market for insulin delivery devices.

Scope of the Report

The Insulin Delivery Devices Market segmented into Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors, and Insulin Pump further segmented into the Insulin pump, Insulin pump reservoir & Infusion set.

By Management Devices
Insulin Pumps
Insulin Pump Devices (Value and Volume, 2016 - 2026)
Insulin Pump Reservoirs (Value and Volume, 2016 - 2026)
Infusion Sets (Value and Volume, 2016 - 2026)
Insulin Syringes (Value and Volume, 2016 - 2026)
Cartridges in reusable pens (Value and Volume, 2016 - 2026)
Disposable Pens (Value and Volume, 2016 - 2026)
Jet Injectors (Value and Volume, 2016 - 2026)
Geography
North America
United States (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Canada (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of North America (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Europe
France (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Germany (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Italy (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Spain (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
United Kingdom (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Russia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Europe (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Latin America
Mexico (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Brazil (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Latin America (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Asia-Pacific
Japan (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
South Korea (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
China (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
India (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Australia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Vietnam (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Malaysia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Indonesia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Philippines (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Thailand (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Asia-Pacific (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Middle-East and Africa
Saudi Arabia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Iran (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Egypt (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Oman (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
South Africa (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

Report scope can be customized per your requirements. Click here.

Key Market Trends

Insulin Pump is expected to grow with the highest CAGR

Insulin Pump held 8.3% of the market share in the insulin delivery devices market in 2020 and is expected to grow with the CAGR of 7% in the market because of the increasing technological advancement and its preference over other traditional methods due to continuous insulin administration. The market also benefits massively from the constant rise in the number of vendors, R&D activities, technological advancements in products, and the easy availability of advanced products across the world. Moreover, favorable reimbursement scenarios in developed nations and a constant rise in awareness programs across developing economies are also working in favor of the market.

Insulin Delivery Devices Market Key Trends

The United States held major market share in 2020

In 2020, the United States recorded the highest market share with more than 20% in the insulin delivery devices market followed by Japan and India. The rising diabetic population and the accessibility of technologically advanced devices are the factors contributing to the high market growth in the United States. According to Mordor intelligence statistics in 2020, around 33 million people in the United States had diabetes; among them, approximately 25.8 million patients diagnosed, whereas about 7.1 million patients remained undiagnosed. Thus, the large patient base suffering from diabetes and its growing prevalence is expected to boost the growth in this region.

Insulin Delivery Devices Market Growth by Region

Competitive Landscape

The Insulin Pens and Insulin Pumps market is consolidated with few players that accounted for a significant market share in 2020. On the other hand, the Insulin syringe market is highly fragmented with several local players. Mergers and acquisitions that happened between the players in the recent past helped the companies strengthen their market presence. For instance, In July 2020, Medtronic PLC and Tandem Diabetes Care Inc. announced that they entered into a non-exclusive patent cross-license agreement for certain technologies in the field of diabetes. 

RECENT DEVELOPMENTS

In 2020, Gan & Lee’s insulin glargine injection and insulin glargine injection (prefilled pen) obtained the registration certificates from the Brazilian National Health Surveillance Agency (ANVISA). Following this, in early 2021, the first shipments of these products were successfully delivered to Brazil.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. Market Segmentation

    1. 5.1 By Management Devices

      1. 5.1.1 Insulin Pumps

        1. 5.1.1.1 Insulin Pump Devices (Value and Volume, 2016 - 2026)

        2. 5.1.1.2 Insulin Pump Reservoirs (Value and Volume, 2016 - 2026)

        3. 5.1.1.3 Infusion Sets (Value and Volume, 2016 - 2026)

      2. 5.1.2 Insulin Syringes (Value and Volume, 2016 - 2026)

      3. 5.1.3 Cartridges in reusable pens (Value and Volume, 2016 - 2026)

      4. 5.1.4 Disposable Pens (Value and Volume, 2016 - 2026)

      5. 5.1.5 Jet Injectors (Value and Volume, 2016 - 2026)

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States (Value and Volume, 2016 - 2026)

          1. 5.2.1.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.1.2 Canada (Value and Volume, 2016 - 2026)

          1. 5.2.1.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.1.3 Rest of North America (Value and Volume, 2016 - 2026)

          1. 5.2.1.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      2. 5.2.2 Europe

        1. 5.2.2.1 France (Value and Volume, 2016 - 2026)

          1. 5.2.2.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.2.2 Germany (Value and Volume, 2016 - 2026)

          1. 5.2.2.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.2.3 Italy (Value and Volume, 2016 - 2026)

          1. 5.2.2.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        4. 5.2.2.4 Spain (Value and Volume, 2016 - 2026)

          1. 5.2.2.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        5. 5.2.2.5 United Kingdom (Value and Volume, 2016 - 2026)

          1. 5.2.2.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        6. 5.2.2.6 Russia (Value and Volume, 2016 - 2026)

          1. 5.2.2.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        7. 5.2.2.7 Rest of Europe (Value and Volume, 2016 - 2026)

          1. 5.2.2.7.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      3. 5.2.3 Latin America

        1. 5.2.3.1 Mexico (Value and Volume, 2016 - 2026)

          1. 5.2.3.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.3.2 Brazil (Value and Volume, 2016 - 2026)

          1. 5.2.3.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.3.3 Rest of Latin America (Value and Volume, 2016 - 2026)

          1. 5.2.3.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      4. 5.2.4 Asia-Pacific

        1. 5.2.4.1 Japan (Value and Volume, 2016 - 2026)

          1. 5.2.4.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.4.2 South Korea (Value and Volume, 2016 - 2026)

          1. 5.2.4.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.4.3 China (Value and Volume, 2016 - 2026)

          1. 5.2.4.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        4. 5.2.4.4 India (Value and Volume, 2016 - 2026)

          1. 5.2.4.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        5. 5.2.4.5 Australia (Value and Volume, 2016 - 2026)

          1. 5.2.4.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        6. 5.2.4.6 Vietnam (Value and Volume, 2016 - 2026)

          1. 5.2.4.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        7. 5.2.4.7 Malaysia (Value and Volume, 2016 - 2026)

          1. 5.2.4.7.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        8. 5.2.4.8 Indonesia (Value and Volume, 2016 - 2026)

          1. 5.2.4.8.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        9. 5.2.4.9 Philippines (Value and Volume, 2016 - 2026)

          1. 5.2.4.9.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        10. 5.2.4.10 Thailand (Value and Volume, 2016 - 2026)

          1. 5.2.4.10.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        11. 5.2.4.11 Rest of Asia-Pacific (Value and Volume, 2016 - 2026)

          1. 5.2.4.11.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      5. 5.2.5 Middle-East and Africa

        1. 5.2.5.1 Saudi Arabia (Value and Volume, 2016 - 2026)

          1. 5.2.5.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.5.2 Iran (Value and Volume, 2016 - 2026)

          1. 5.2.5.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.5.3 Egypt (Value and Volume, 2016 - 2026)

          1. 5.2.5.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        4. 5.2.5.4 Oman (Value and Volume, 2016 - 2026)

          1. 5.2.5.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        5. 5.2.5.5 South Africa (Value and Volume, 2016 - 2026)

          1. 5.2.5.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        6. 5.2.5.6 Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)

          1. 5.2.5.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes population (2016- 2026)

    2. 6.2 Type-2 Diabetes population (2016 - 2026)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company profiles

      1. 7.1.1 Novo Nordisk

      2. 7.1.2 Sanofi

      3. 7.1.3 Eli Lilly and Company

      4. 7.1.4 Medtronic

      5. 7.1.5 Insulet

      6. 7.1.6 Ypsomed

      7. 7.1.7 Becton, Dickinson and Company

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Insulin Delivery Devices Market market is studied from 2016 - 2026.

The Insulin Delivery Devices Market is growing at a CAGR of 3.5% over the next 5 years.

The Insulin Delivery Devices Market is valued at 33 Billion USD in 2016.

The Insulin Delivery Devices Market is valued at 42 Billion USD in 2026.

North America is growing at the highest CAGR over 2021- 2026.

Asia Pacific holds highest share in 2020.

Novo Nordisk, Medtronic, Sanofi, Ypsomed, Eli Lilly and Company are the major companies operating in Insulin Delivery Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!